Telomerase activity in primary prostate cancer

Journal of Urology

Volumn 157, Issue 3, 1997, Pages 1161-1165

  Lin, Yi ^a   Uemura, Hiroji ^a   Fujinami, Kiyoshi ^a   Hosaka, Masahiko ^a   Harada, Masaoki ^a   Kubota, Yoshinobu ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

prostate cancer; telomerase; TRAP assay

Indexed keywords

TELOMERASE; TUMOR MARKER;

ARTICLE; BONE METASTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

EID: 0031021828     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65160-7     Document Type: Article

References (20)

1. Waters, D. J., Janovitz, E. B. and Chan, T. C. K.: Spontaneous metastasis of PC-3 cells in athymic mice after implantation in orthotopic or ectopic microenvironments. Prostate, 26: 227, 1995.
2. Kubota, Y., Shuin, T., Uremura, H., Fujinami, K, Miyamoto, H., Torigoe, S., Dobashi, Y., Kitamura, H., Iwasaki, Y., Danenberg, K. and Danenberg, P. V.: Tumor suppressor gene P53 mutations in human prostate cancer. Prostate, 27: 18, 1995.
3. Kubota, Y., Fujinami, K., Uemura, H., Dobashi, Y., Miyamoto, H., Iwasaki, Y., Kitamura, H. and Shuin, T.: Retinoblastoma gene mutations in primary human prostate cancer. Prostate, 27: 314, 1995.
4. Friedrich, B., Gronberg, H., Landstrom, M., Gullberg, M. and Bergh, A.: Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma. Prostate, 27: 102, 1995.
5. Mehle, C., Ljungberg, B. and Roos, G.: Telomere shortening in renal cell carcinoma. Cancer Res., 54: 236, 1994.
6. Zakian, V. A.: Telomeres: begining to understand the end. Science, 270: 1601, 1995.
7. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L., Avilion, A. A., Chiu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J. H., Le, S. Y., West, M. D., Harley, C. B., Andrews, W. H., Greider, C. W. and Villeponteau, B.: The RNA component of human telomerase. Science, 269: 1236, 1995.
8. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L. and Shay, J. W.: Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011, 1994.
9. Counter, C. M., Hirte, H. W., Bacchetti, S. and Harley, C. B.: Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA, 91: 2900, 1994.
10. Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyzek, M. A. and Shay, J. W.: Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med., 1: 249, 1995.
11. Chadeneau, C., Hay, K., Hirte, H. W., Gallinger, S. and Bacchetti, S.: Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res., 55: 2533, 1995.
12. Lin, Y., Miyamoto, H., Fujinami, K., Uemura, H., Hosaka, M., Iwasaki, Y. and Kubota, Y.: Telomerase activity in human bladder cancer. Clin. Cancer Res., 2: 929, 1996.
13. Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B. and Lansdorp, P. M.: Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA, 91: 9857, 1994.
14. Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, S., Shay, J. W. and Coffey, D. S.: Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res., 56: 218, 1996.
15. Japanese Urological Association and the Japanese Society of Pathology. General Rule for Clinical and Pathological Studies on Prostate Cancer. 2nd ed. (In Japanese). Tokyo: Kanehara Press, 1992.
16. Wright, W. E., Shay, J. W. and Piatyszek, M. A.: Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res., 23: 3794-3795, 1995.
17. Tahara, H., Kaniyasu, H., Yokozake, H., Yasui, W., Shay, J. W., Ide, T., and Tahara, E.: Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin. Cancer Res., 1: 1245, 1995.
18. Hiyama, E., Yokoyama, T., Tatsumoto, N., Hiyama, K., Imamura, Y., Murakami, Y., Kodama, T., Piatyszek, M. A., Shay, J. W. and Matsuura, Y.: Telomerase activity in gastric cancer. Cancer Res., 55: 3258, 1995.
19. Takezawa, Y., Ito, K., Suzuki, K., Fukabori, Y., Yamanaka, H., Honma S., Mieda, M., Hamataki, N. and Kushitani, M.: Effects of a new steroidal antiandrogen, TZP-4238 (17-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3, 20-dione), on spontaneously developed canine benign prostatic hyperplasia. Prostate, 27: 321, 1995.
20. Hiyama, E., Hiyama, K., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A. and Shay, J. W.: Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst., 87: 895, 1995.